Parmax Pharma Limited (BOM:540359)
66.69
+1.30 (1.99%)
At close: Jun 17, 2026
75.50% (1Y)
| Market Cap | 249.51M +51.6% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 3.74M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,824 |
| Open | 66.69 |
| Previous Close | 65.39 |
| Day's Range | 66.69 - 66.69 |
| 52-Week Range | 22.60 - 66.69 |
| Beta | 0.29 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 30, 2026 |